These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report. Broughton A; Cosyns JP; Jadoul M Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560 [TBL] [Abstract][Full Text] [Related]
5. [Interferon ß, nephrotic syndrome and thrombotic microangiopathy]. Quintana LF; Campistol JM Med Clin (Barc); 2015 Jan; 144(2):65-6. PubMed ID: 25458512 [No Abstract] [Full Text] [Related]
6. Thrombotic microangiopathy associated with interferon beta. Hunt D; Kavanagh D; Drummond I; Weller B; Bellamy C; Overell J; Evans S; Jackson A; Chandran S N Engl J Med; 2014 Mar; 370(13):1270-1. PubMed ID: 24670186 [No Abstract] [Full Text] [Related]
7. Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis. Omoto S; Utsumi T; Matsuno H; Terasawa Y; Iguchi Y Intern Med; 2018 Mar; 57(5):741-744. PubMed ID: 29151517 [TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon-beta treatment for multiple sclerosis. Mrabet S; Dahmane R; Raja B; Fradi A; Aicha NB; Sahtout W; Azzabi A; Guedri Y; Zellama D; Achour A; Sfar I; Goucha R; Abdessayed N; Mokni M Br J Clin Pharmacol; 2023 May; 89(5):1682-1685. PubMed ID: 36480744 [TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathy and accelerated hypertension after treatment with interferon beta. Pérez EP; Sánchez de la Nieta García MD; López LG; Hernández FR Nefrologia (Engl Ed); 2018; 38(5):564-565. PubMed ID: 29433840 [No Abstract] [Full Text] [Related]
10. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report. Liou AA; Skiver BM; Yates E; Persad P; Meyer D; Farland AM; Rocco MV Am J Kidney Dis; 2019 May; 73(5):615-619. PubMed ID: 30528935 [TBL] [Abstract][Full Text] [Related]
11. The Case | The young philosopher with multiple sclerosis and proteinuria. Piccoli GB; Capobianco M; Vigotti FN; Naretto C; Narioz C; Brocheriou I; Roccatello D Kidney Int; 2016 Apr; 89(4):961-3. PubMed ID: 26994580 [No Abstract] [Full Text] [Related]
12. Cabozantinib-induced renal thrombotic microangiopathy. La Manna G; Baraldi O; Corradetti V; Comai G Nephrology (Carlton); 2018 Jan; 23(1):96-97. PubMed ID: 29250919 [No Abstract] [Full Text] [Related]
13. Favorable outcome of interferon-beta associated thrombotic microangiopathy following treatment with corticosteroids, plasma exchange and rituximab: A case report. Gerischer LM; Siebert E; Janke O; Jungehuelsing GJ; Ruprecht K Mult Scler Relat Disord; 2016 Nov; 10():63-65. PubMed ID: 27919500 [TBL] [Abstract][Full Text] [Related]
15. Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients. Izzedine H; Mathian A; Albiges L; Champiat S; Brocheriou I Eur J Cancer; 2021 May; 149():34-36. PubMed ID: 33819719 [No Abstract] [Full Text] [Related]
16. Case report of thrombotic microangiopathy associated with subcutaneous interferon beta-1a: an emerging complication? Azkune Calle I; Sánchez Menoyo JL; Ruiz Ojeda J; García Moncó JC; Etxeguren Urkixo I Neurologia; 2016 Sep; 31(7):508-9. PubMed ID: 25449964 [No Abstract] [Full Text] [Related]
17. Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis. Rot U; Ledinek AH Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S79-81. PubMed ID: 24321162 [TBL] [Abstract][Full Text] [Related]
18. Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature. Kavanagh D; McGlasson S; Jury A; Williams J; Scolding N; Bellamy C; Gunther C; Ritchie D; Gale DP; Kanwar YS; Challis R; Buist H; Overell J; Weller B; Flossmann O; Blunden M; Meyer EP; Krucker T; Evans SJ; Campbell IL; Jackson AP; Chandran S; Hunt DP Blood; 2016 Dec; 128(24):2824-2833. PubMed ID: 27663672 [TBL] [Abstract][Full Text] [Related]
19. Tip variant focal segmental glomerulosclerosis associated with interferon-β treatment of multiple sclerosis. Evans R; Rudd P; Bass P; Harber M BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24503666 [No Abstract] [Full Text] [Related]